Focused insights: Data implications of ADCs in NSCLC treatment

24/01/2025 21 min Episodio 469
Focused insights: Data implications of ADCs in NSCLC treatment

Listen "Focused insights: Data implications of ADCs in NSCLC treatment"

Episode Synopsis

touchFOCUS for touchRESPIRATORY
Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these data may impact clinical practice in the future.
The expert

Prof. Céline Mascaux, Strasbourg University, Strasbourg, France

This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website: 
www.touchrespiratory.org/ADCs-in-NSCLC

More episodes of the podcast touchPODCAST